Overview

This trial is active, not recruiting.

Condition prostate cancer
Treatment questionnaires of quality of life
Sponsor Memorial Sloan Kettering Cancer Center
Collaborator University School of Medicine(VA-NYU)
Start date January 2010
End date December 2016
Trial size 225 participants
Trial identifier NCT00581672, 07-125, NCT00602654

Summary

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
Black men with prostate cancer
questionnaires of quality of life
Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.

Primary Outcomes

Measure
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.
time frame: within one to three weeks of receiving their PSA scores from their physician

Secondary Outcomes

Measure
To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.
time frame: within one to three weeks of receiving their PSA scores from their physician

Eligibility Criteria

Male participants at least 18 years old.

Inclusion Criteria: - 18 years of age or older - Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results - Diagnosis of prostate cancer - Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic). - Ability to comprehend and complete questionnaires in English Exclusion Criteria: - Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol - Other non-Black or non-African-American ethnic groups

Additional Information

Official title Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Principal investigator Christian Nelson, PhD
Trial information was received from ClinicalTrials.gov and was last updated in October 2015.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.